United Capital Financial Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.45M | Buy |
|
|||||
|
2025
Q2 | $1.17M | Sell |
|
|||||
|
2025
Q1 | $1.49M | Sell |
|
|||||
|
2024
Q4 | $1.69M | Sell |
|
|||||
|
2024
Q3 | $3.16M | Sell |
|
|||||
|
2024
Q2 | $3.18M | Buy |
|
|||||
|
2024
Q1 | $2.88M | Sell |
|
|||||
|
2023
Q4 | $2.93M | Sell |
|
|||||
|
2023
Q3 | $3.65M | Sell |
|
|||||
|
2023
Q2 | $3.35M | Buy |
|
|||||
|
2023
Q1 | $3.78M | Buy |
|
|||||
|
2022
Q4 | $2.7M | Buy |
|
|||||
|
2022
Q3 | $1.07M | Buy |
|
|||||
|
2022
Q2 | $891K | Sell |
|
|||||
|
2022
Q1 | $1.09M | Sell |
|
|||||
|
2021
Q4 | $1.03M | Sell |
|
|||||
|
2021
Q3 | $1.04M | Sell |
|
|||||
|
2021
Q2 | $1.08M | Sell |
|
|||||
|
2021
Q1 | $1.09M | Sell |
|
|||||
|
2020
Q4 | $1.15M | Buy |
|
|||||
|
2020
Q3 | $1.17M | Buy |
|
|||||
|
2020
Q2 | $1.26M | Buy |
|
|||||
|
2020
Q1 | $586K | Buy |
|
|||||
|
2019
Q4 | $332K | Buy |
|
|||||
|
2019
Q3 | $101K | Sell |
|
|||||
|
2019
Q2 | $298K | Buy |
|
|||||
|
2019
Q1 | $266K | Sell |
|
|||||
|
2018
Q4 | $500K | Buy |
|
|||||
|
2018
Q3 | $516K | Buy |
|
|||||
|
2018
Q2 | $208K | Sell |
|
|||||
|
2018
Q1 | $235K | Buy |
|
|||||
|
2017
Q4 | $214K | Sell |
|
|||||
|
2017
Q3 | $263K | Buy |
|
|||||
|
2017
Q2 | $236K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $232K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $296K | Buy |
|
|||||
|
2015
Q2 | $263K | Buy |
|